SG3 Management, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2021$1,000
-66.7%
2,0000.0%0.00%
Q3 2021$3,000
-25.0%
2,0000.0%0.00%
Q2 2021$4,0000.0%2,0000.0%0.00%
Q1 2021$4,000
+100.0%
2,000
+33.3%
0.00%
Q4 2020$2,000
-99.7%
1,500
-98.4%
0.00%
-100.0%
Q2 2020$797,000
+52.4%
95,000
-4.9%
0.06%
-21.4%
Q1 2020$523,00099,9000.07%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders